AcEnTrApBiP-D3
- 价格: ¥99/瓶
- 发布日期: 2019-04-01
- 更新日期: 2025-10-15
产品详请
| 产地 |
加拿大
|
| 品牌 |
进口
|
| 货号 |
01-637202
|
| 包装规格 |
5mg,
|
| 纯度 |
98%
|
| CAS编号 |
1061715-90-9
|
| 别名 |
(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4'-fluoro-2'-(methoxy-d3)-5'-(1-methylethyl)-4-(trifluoromethyl)[1,1'-biphenyl]-2-yl]methyl]-4-methyl-2-oxazolidinone; (4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4'-fluoro-5'-isopropyl-2'-(methoxy-d3)-4-(trifluoromethyl)biphenyl-2-yl]methyl]-4-methyl-1,3-oxazolidin-2-one; MK 0859-d3;
|
货号:01-637202
中文名称:AcEnTrApBiP-D3
英文名称:(+)-Anatoxin-a
CAS号:1061715-90-9
重量:5mg
重量:
分子式:C30H22D3F10NO3
别名:(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4'-fluoro-2'-(methoxy-d3)-5'-(1-methylethyl)-4-(trifluoromethyl)[1,1'-biphenyl]-2-yl]methyl]-4-methyl-2-oxazolidinone; (4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4'-fluoro-5'-isopropyl-2'-(methoxy-d3)-4-(trifluoromethyl)biphenyl-2-yl]methyl]-4-methyl-1,3-oxazolidin-2-one; MK 0859-d3;
应用介绍:A labelled orally active and potent cholesterol ester transfer protein (CETP) inhibitor for the treatment of atherosclerosis, in particular dyslipidemia.